Drug recall D-0496-2024
Product
Cefdinir for Oral Suspension USP 250 mg/5 mL (60 mL when reconstituted), 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046, India, NDC 68180-723-04
Reason for recall
Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
Lots and codes
Lot # F305442, Exp 8/30/2025
Recall details
- Recalling firm
- Lupin Pharmaceuticals Inc., Baltimore, MD
- Quantity
- 17,070 bottles
- Distribution
- USA nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- April 24, 2024
- Terminated
- April 29, 2025
Related products
- Cefdinir – drug information
- NDC 68180-723 Cefdinir · Cefdinir 250 mg/5mL · Lupin Pharmaceuticals, Inc.
- NDC 68180-722 Cefdinir · Cefdinir 125 mg/5mL · Lupin Pharmaceuticals, Inc.